Loading
US
Urovant Sciences Ltd. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Sumitomo Chemical Co., Ltd., was filed 21 Feb 2020.
Urovant Sciences Ltd.: what insiders have been doing
Urovant Sciences Ltd. is a listed company. Filings by its managers are published through SEC (Form 4). Urovant Sciences Ltd. has had no insider filing for more than a year; the last one goes back to 23 July 2020.
Since 2018, the database holds 219 purchases and 2 sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
246
Thresholds
n/a
Buy Volume
€359M
219 ops. · all time
Sell Volume
€1M
2 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2020FY ended March 2020 · cache
Income statement
Net income-130.8M
Last declaration on 23 July 2020
Declarations246 total
9,000 shares0Common SharesSEC:0001209191-20-043489:0
9,000 shares0Common SharesSEC:0001209191-20-043482:0
9,000 shares0Common SharesSEC:0001209191-20-043480:0
9,000 shares0Common SharesSEC:0001209191-20-043484:0
108,647 shares0Common SharesSEC:0001209191-20-034226:0
83,149 shares0Common SharesSEC:0001209191-20-026844:0
63,659 shares0Common SharesSEC:0001209191-20-026835:0
44,346 shares0Common SharesSEC:0001209191-20-026839:0
77,606 shares0Common SharesSEC:0001209191-20-026841:0
12,873 shares@ US$13.0812.5% of flowCommon StockSEC:0000950103-20-003118:0
Canonical exit: 19 May 2020 (T+90)
15,165 shares@ US$13.0814.7% of flowCommon StockSEC:0000950103-20-003118:1
Canonical exit: 19 May 2020 (T+90)
75,212 shares@ US$13.0872.8% of flowCommon StockSEC:0000950103-20-003118:2
Canonical exit: 19 May 2020 (T+90)
180,000 shares@ US$3.8613.9% of flowCommon SharesSEC:0000899243-20-005517:0
104,788 shares@ US$13.0827.4% of flowCommon SharesSEC:0000899243-20-005517:1
75,212 shares@ US$13.0819.7% of flowCommon SharesSEC:0000899243-20-005517:2
50,000 shares@ US$6.8834.5% of flowCommon SharesSEC:0000899243-20-005516:0
34,835 shares@ US$13.0845.7% of flowCommon SharesSEC:0000899243-20-005516:1
15,165 shares@ US$13.0819.9% of flowCommon SharesSEC:0000899243-20-005516:2
12,480 shares0Common SharesSEC:0001209191-20-003281:0
12,480 shares0Common SharesSEC:0001209191-20-003287:0
12,480 shares0Common SharesSEC:0001209191-20-003283:0
12,480 shares0Common SharesSEC:0001209191-20-003285:0
50,000 shares0Common SharesSEC:0000899243-20-000881:0
32,833 shares0Common SharesSEC:0000899243-20-000882:0
62,128 shares0Common SharesSEC:0000899243-20-000883:0
25 of 246 declarations
About Urovant Sciences Ltd.
Urovant Sciences Ltd. is a biopharmaceutical company focused on developing treatments for urological disorders. It is listed on NASDAQ under the ticker symbol UROV.
